Skip to main content
. Author manuscript; available in PMC: 2016 Jun 8.
Published in final edited form as: Mol Microbiol. 2015 Dec 22;99(6):999–1014. doi: 10.1111/mmi.13280

Table 1.

Activity of Plasmodium PSD inhibitors against Plasmodium falciparum 3D7 and human foreskin fibroblast (HFF).

Compound ID MW ALogP P. falciparum 3D7
(EC50 in μM)
HFF (IC50
in μM)
SI:
HFF/3D7
MMV665927 282.55 2.87 0.555 16.2 29
MMV666106 436.57 5.13 1.07 >32 >30
MMV019555 478.67 8.06 0.376 4.06 11
MMV666026 288.30 3.66 3.845 >32 >8
MMV019918 383.71 3.93 0.8 4.028 5
MMV665949 281.13 4.12 2.47 >32 >13
MMV666025 500.19 5.97 1.26 >32 >25
MMV396594 490.66 5.52 1.06 >32 >30
MMV665971 484.95 4.86 1.14 16.594 >15
MMV019064 493.60 4.62 1.3 >32 25
MMV001239 400.45 3.74 15 >32 >2
MMV007764 256.39 4.93 0.716 19.329 >27
MMV019266 312.41 4.46 0.615 >32 >52
MMV000356 379.26 4.16 1.03 >32 >31
MMV007285 298.77 4.56 4 >32 >8
MMV011099 275.31 3.52 0.242 >32 >132
MMV665797 364.44 5.02 0.584 14.254 24
MMV020243 362.43 2.54 1.15 23.776 21

The selectivity index (SI) for each compound was determined as a ratio of HFF IC50/3D7 EC50. Data were obtained from MMV and Chembl2028072.